Clinical Trial Update: A Clinical Study Of Camrelizumab With Or Without Radiotherapy In The Treatment Of Esophageal Cancer [Phase 2]

View source ↗

Summary

Phase 2 clinical trial evaluating camrelizumab with or without radiotherapy for esophageal cancer is ongoing, with status currently unknown.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Esophageal Cancer

Drugs mentioned

• Camrelizumab (camrelizumab)

Snippet

Sponsor: Zhejiang Cancer Hospital | Conditions: Esophageal Cancer | Phase 2 | Status: UNKNOWN